Skip to main content

Joenja

Generic: Leniolisib

Link broken·Jun 1, 2026
Manufacturer
Pharming
NDC
71274-170
RxCUI
2633015
Route
ORAL
ICD-10 indication
D81.89

Affordability Check

How much will you actually pay for Joenja?

In 30 seconds, see every legitimate way to afford Joenja — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Joenja

What is this medication? Joenja is a prescription medicine used to treat activated phosphoinositide 3-kinase delta syndrome, which is more commonly referred to as APDS. APDS is a rare genetic condition that impairs the immune system, making it difficult for the body to fight off infections and leading to various health complications. This medication specifically targets the underlying cause of the disorder by regulating an overactive enzyme that disrupts normal immune cell function.

The drug is approved for use in adults and pediatric patients who are 12 years of age and older. By acting as a selective inhibitor, Joenja helps to balance the immune response, which can reduce the size of enlarged lymph nodes and the spleen while also decreasing the frequency of respiratory infections. It is taken orally and represents the first targeted treatment option available for patients diagnosed with this specific primary immunodeficiency.

Copay & patient assistance

  • Patient Copay Amount: Not Publicly Available
  • Maximum Annual Benefit Limit: Not Publicly Available
  • Core Eligibility Restrictions: Not Publicly Available
  • RxBIN, PCN, and Group numbers: Not Publicly Available

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How Joenja appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).

Covered by plans

4%

226 of 5,499 plans

Most common tier

Tier 5

On 77% of covering formularies

Prior authorization required

100%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)3
14%
Tier 2 (generic)1
5%
Tier 5 (specialty)17
77%
Tier 61
5%

Step therapy: 0% of formularies

Quantity limits: 82% of formularies

Coverage breadth: 22 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

—

Medicare Part D

———

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.